Dinesh V. Ph D. Patel, President and CEO at Protagonist Therapeutics, Inc (PTGX), sold 35,000 shares at $35.19 ($1.2M) on 2024-06-07, disclosed to the SEC on 2024-06-11.
Scheduled sale ($1.2M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PTGX | SELL | 2026-03-25 | $5.5M | — | Filing → |
| PTGX | SELL | 2026-01-27 | $4.1M | — | Filing → |
| PTGX | SELL | 2026-01-21 | $2.8M | — | Filing → |